Shared on04 Sep 25
Fresenius Medical Care's key valuation metrics, including the future P/E ratio and consensus revenue growth forecasts, remained effectively unchanged, resulting in a stable analyst price target of €50.26. What's in the News Fiscal 2025 guidance forecasts positive to low-single digit revenue growth and high-teens to high-twenties percent operating income growth (excluding special items).
Shared on23 Apr 25Fair value Decreased 0.81%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 6.02%
AnalystConsensusTarget has increased revenue growth from 3.0% to 3.6%.
Shared on02 Apr 25Fair value Increased 0.81%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 0.46%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 1.42%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 1.47%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.